References
- Rotschild A, Ling E W, Puterman M L, Farquharson D. Neonatal outcome after prolonged preterm rupture of membranes. Am J Obstet Gynecol 1990; 162: 46–52
- Rib D M, Sherer D M, Woods J R, Jr. Maternal and neonatal outcome associated with prolonged premature rupture of membranes below 26 weeks' gestation. Am J Perinatol 1993; 10: 369–373
- Mercer B M, Crocker L G, Boe N M, Sibai B M. Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: A randomized trial. Am J Obstet Gynecol 1993; 169: 775–782
- Cox S M, Williams M L, Leveno K J. The natural history of preterm ruptured membranes: What to expect of expectant management. Obstet Gynecol 1988; 71: 558–562
- Lieman J M, Brumfield C G, Carlo W, Ramsey P S. Preterm premature rupture of membranes: Is there an optimal gestational age for delivery?. Obstet Gynecol 2005; 105: 12–17
- American College of Obstetricians and Gynecologists. Premature rupture of membranes. ACOG Practice Bulletin No. 1. ACOG, Washington, DC 1998
- Mercer B M, Miodovnik M, Thurnau G R, Goldenberg R L, Das A F, Ramsey R D, Rabello Y A, Meis P J, Moawad A H, Iams J D, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: A randomized controlled trial. JAMA 1997; 278: 989–995
- Lovett S M, Weiss J D, Diogo M J, Williams P T, Garite T J. A prospective, double-blind, randomized, controlled clinical trial of ampicillin–sulbactam for preterm premature rupture of membranes in women receiving antenatal corticosteroid therapy. Am J Obstet Gynecol 1997; 176: 1030–1038
- Morales W J, Angel J L, O'Brien W F, Knuppel R A. Use of ampicillin and corticosteroids in premature rupture of membranes: A randomized study. Obstet Gynecol 1989; 73: 721–726
- Garite T J. Management of premature rupture of membranes. Clin Perinatol 2001; 28: 837–844
- Ohlsson A. Treatment of preterm premature rupture of the membranes: A meta-analysis. Am J Obstet Gynecol 1989; 160: 890–906
- Gopalani S, Krohn M, Meyn L, Hitti J, Crombleholma W R. Contemporary management of preterm premature rupture of membranes: Determinants of latency and neonatal outcome. Obstet Gynecol Surv 2005; 60: 16–17
- Furman B, Shoham-Vardi I, Bashiri A, Erez O, Mazor M. Clinical significance and outcome of preterm prelabor rupture of membranes: Population-based study. Eur J Obstet Gynecol Reprod Biol 2000; 92: 209–216
- Mercer B M, Arheart K L. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes. Lancet 1995; 346: 1271–1279
- Moretti M, Sibai B H. Maternal and perinatal outcome of expectant management of premature rupture of membranes in the midtrimester. Am J Obstet Gynecol 1988; 159: 390–396
- Dale P O, Tanbo T, Bendvold E, Moe N. Duration of the latency period in preterm premature rupture of the membranes. Maternal and neonatal consequences of expectant management. Eur J Obstet Gynecol Reprod Biol 1989; 30: 257–262
- Savitz D A, Ananth C V, Luther E R, Thorp J M, Jr. Influence of gestational age on the time form spontaneous rupture of the chorioamniotic membranes to the onset of labor. Am J Perinatol 1997; 14: 129–133
- Kurkinen-Raty M, Koivisto M, Jouppila P. Perinatal and neonatal outcome and late pulmonary sequelae in infants born after preterm premature rupture of membranes. Obstet Gynecol 1998; 92: 408–415
- Major C A, Kitzmiller J L. Perinatal survival with expectant management of midtrimester rupture of membranes. Am J Obstet Gynecol 1990; 163: 838–844
- Philipson E H, Hoffman D S, Hansen G O, Ingardia C J. Preterm premature rupture of membranes: Experience with latent periods in excess of seven days. Am J Perinatol 1994; 11: 416–419
- Yoder B A, Gordon M C, Barth W H, Jr. Late-preterm birth: does the changing obstetric paradigm alter the epidemiology of respiratory complications?. Obstet Gynecol 2008; 111: 814–822